Lookup NU author(s): Gordon Taylor,
Professor Herbie Newell,
Professor Nicola Curtin
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Hypoxanthine (HPX) uptake was investigated in four human tumour cell lines previously characterised as being sensitive (ds: A549 and MCF7) or insensitive (di: COR-L23 and T-47D) to dipyridamole (DP)-induced inhibition of HPX rescue from antipurine antifolate-induced growth inhibition. The aim of the study was to determine the mechanism underlying the differential sensitivity of HPX rescue to DP. The time-course of HPX uptake in the two ds cell lines was different in comparison to the two di cell lines. The initial rate of HPX uptake in the di cell lines was more rapid than in the ds cell lines such that at 60 sec the amount of HPX taken up by the former was 2-6 times higher than that taken up by the later. The Kt and Tmax for HPX transport in di COR-L23 cells were 870 μM and 4.75 μM/106 cells/min and 1390 μM and 1.78 μM/106 cells/min in ds A549 cells. HPX transport was not sodium-dependent in these cells. Equilibrative nucleoside transporter 2 (ENT2)-mediated thymidine transport was also higher in di cells. DP inhibited HPX uptake into ds cell lines by ≥48% and by ≤20% in the di cell lines. Competition studies with HPX and thymidine transport via ENT2 indicated an overlap between nucleoside and nucleobase transport transporters in the breast cancer cell lines (MCF7 and T-47D). These studies showed that more rapid and extensive HPX uptake, as well as reduced sensitivity to DP inhibition, is associated with the inability of DP to prevent HPX rescue from antipurine antifolate-induced growth inhibition in certain human tumour cell lines. © 2001 Elsevier Science Inc.
Author(s): Marshman, E., Taylor, G., Thomas, H., Newell, D.R., Curtin, N.J.
Publication type: Article
Publication status: Published
Journal: Biochemical Pharmacology
Print publication date: 15/02/2001
ISSN (print): 0006-2952
ISSN (electronic): 1873-2968
PubMed id: 11226382
Altmetrics provided by Altmetric